West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
MedPage Today7h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Healio7h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
News Medical1d
Pneumovax 23
The tip cap and plunger stopper of the pre-filled syringe are not made with natural rubber latex. The vial stopper is not made with natural rubber latex.
pharmaphorum1d
How can the pharma industry navigate issues in the global supply chain to minimise drug shortages?
The extraordinary scenario of producing vaccines for a global pandemic led to a well-documented shortage of vials, stoppers, and syringes, and finding a solution is no easy task. For example ...
News Medical2d
Gardasil 9
The tip cap and plunger stopper of the pre-filled syringe are not made with natural rubber latex. The vial stopper is not made with natural rubber latex. This leaflet was prepared in November 2024.